Get the tools used by (smart)2 investors.

P/E Ratio (Adjusted) for Cumberland Pharmaceuticals Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

CPIX: Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, ...

4.06 USD
Price
USD
Fair Value
Upside
1.04 - 7.25
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Cumberland Pharmaceuticals Inc's P/E Ratio (Adjusted):

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.0x500.0x1,000.0x1,500.0x

Performance Summary
  • Cumberland Pharmaceuticals's latest twelve months p/e ratio (adjusted) is -8.3x
  • Cumberland Pharmaceuticals's p/e ratio (adjusted) for fiscal years ending December 2020 to 2024 averaged -6.7x.
  • Cumberland Pharmaceuticals's operated at median p/e ratio (adjusted) of -6.0x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Cumberland Pharmaceuticals's p/e ratio (adjusted) peaked in December 2022 at -4.0x.
  • Cumberland Pharmaceuticals's p/e ratio (adjusted) hit its 5-year low in December 2023 of -9.8x.
  • Cumberland Pharmaceuticals's p/e ratio (adjusted) decreased in 2021 (-6.0x, +9.9%) and 2023 (-9.8x, +142.8%) and increased in 2020 (-5.4x, -43.9%), 2022 (-4.0x, -32.2%), and 2024 (-8.3x, -16.1%).

How does Cumberland's P/E Ratio (Adjusted) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Cumberland Pharmaceuticals Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: P/E Ratio (Adjusted)

Hide this widget
pe_ltm_adj
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to P/E Ratio (Adjusted) in the valuation category include:

View Full List

Search for metric or datapoint

P/E Ratio (Adjusted)

Indicates the multiple of earnings, adjusted for usual items, that stock investors are willing to pay for one share of the firm.

Definition of P/E Ratio (Adjusted)

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-84.3x-39.3x5.7x81.0x0400800

The chart above depicts the distribution of p/e ratio (adjusted) for companies operating in the Healthcare sector in the Developed economic region. Over 2,430 companies were considered in this analysis, and 2,339 had meaningful values. The average p/e ratio (adjusted) of companies in the sector is 0.9x with a standard deviation of 17.5x.

Cumberland Pharmaceuticals Inc's P/E Ratio (Adjusted) of -8.3x ranks in the 16.6% percentile for the sector. The following table provides additional summary stats:

P/E Ratio (Adjusted) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,437
Included Constituents2,339
Min-83.7x
Max80.4x
Median-1.2x
Mean0.9x
Standard Deviation17.5x

You can find companies with similar p/e ratio (adjusted) using this stock screener.

All rights reserved. Terms Of Use